Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

NCT00004254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

NETWORK

Sponsor class

Conditions

Malignant Mesothelioma

Interventions

DRUG: raltitrexed

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC